Form 4: InfuSystem Executive Receives Equity Compensation

Sentiment:

Statement of Changes in Beneficial Ownership


EVP and Chief HR Officer Jerod Funke was granted stock options and restricted stock units by InfuSystem Holdings, Inc.

Summary

  • Jerod Funke, EVP and Chief HR Officer of InfuSystem Holdings, Inc., received a grant of 23,913 stock options and 11,478 restricted stock units (RSUs).
  • The stock options have an exercise price of $8.37 per share and expire on May 12, 2036.
  • The stock options vest in four equal annual installments starting May 12, 2027.
  • The RSUs vest in three equal annual installments starting May 12, 2027, and convert to common stock on a one-for-one basis.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that carries no significant change to the company's operational or financial outlook.

Positives

  • Equity grants align executive interests with long-term shareholder value creation.
  • Multi-year vesting schedules encourage executive retention.

Negatives

  • The issuance of new equity awards results in potential future dilution for existing shareholders.

Risks

  • Future dilution of share value upon the exercise of options and vesting of RSUs.
  • Market price volatility affecting the value of the granted equity.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on executive compensation structure.

Industry Context

StockSavvy.ai notes that equity-based compensation is a standard practice in the healthcare services sector to incentivize leadership and ensure long-term commitment to corporate strategic goals.

Comparison to Industry Standards

  • The use of multi-year vesting schedules for executive equity is consistent with standard corporate governance practices for publicly traded companies.
  • The grant of both options and RSUs is a common hybrid compensation strategy used to balance performance-based incentives with retention.

Stakeholder Impact

  • Shareholders may experience minor dilution upon the eventual exercise or vesting of these equity instruments.

Next Steps

  • Vesting of stock options beginning May 12, 2027.
  • Vesting of restricted stock units beginning May 12, 2027.

Key Dates

DateDescription
05/12/2026Date of grant for stock options and restricted stock units.
05/12/2027Initial vesting date for both stock options and restricted stock units.
05/12/2029Final vesting date for restricted stock units.
05/12/2036Expiration date for stock options.

Keywords

InfuSystem, INFU, Form 4, Executive Compensation, Stock Options, Restricted Stock Units, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.